KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Colgate Palmolive (CL) Other financing activities (2020 - 2025)

Colgate Palmolive (CL) has 6 years of Other financing activities data on record, last reported at -$13.0 million in Q4 2025.

  • For Q4 2025, Other financing activities rose 85.87% year-over-year to -$13.0 million; the TTM value through Dec 2025 reached $132.0 million, up 245.05%, while the annual FY2025 figure was $132.0 million, 245.05% up from the prior year.
  • Other financing activities reached -$13.0 million in Q4 2025 per CL's latest filing, down from $9.0 million in the prior quarter.
  • Across five years, Other financing activities topped out at $104.0 million in Q2 2025 and bottomed at -$92.0 million in Q4 2024.
  • Average Other financing activities over 5 years is $894736.8, with a median of -$6.0 million recorded in 2021.
  • Peak YoY movement for Other financing activities: tumbled 1400.0% in 2021, then soared 620.0% in 2025.
  • A 5-year view of Other financing activities shows it stood at -$15.0 million in 2021, then skyrocketed by 233.33% to $20.0 million in 2022, then surged by 140.0% to $48.0 million in 2023, then plummeted by 291.67% to -$92.0 million in 2024, then soared by 85.87% to -$13.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other financing activities were -$13.0 million in Q4 2025, $9.0 million in Q3 2025, and $104.0 million in Q2 2025.